Wang Xiu Qing, Shopsowitz Kevin, Lofroth Jack, Wang Xuehai, Peterson Erica, Weng Andrew P, Chen Luke Y C
Department of Pathology and Laboratory Medicine University of British Columbia Vancouver British Columbia Canada.
Faculty of Medicine University of British Columbia Vancouver British Columbia Canada.
EJHaem. 2025 Mar 29;6(2):e1109. doi: 10.1002/jha2.1109. eCollection 2025 Apr.
Lymphocytic variant hypereosinophilic syndrome (L-HES) is a rare disorder characterized by persistent eosinophilia driven by aberrant T-cell populations. Diagnosis remains challenging due to the lack of standardized diagnostic criteria.
We retrospectively analyzed 18 patients diagnosed with L-HES between 2016 and 2023. Comprehensive flow cytometry was performed on peripheral blood samples.
Nine patients demonstrated the classic sCD3CD4CD5CD2CD45ROCD45RA immunophenotype, ranging from 0.6% to 70% of total lymphocytes. Two patients showed variant sCD3CD4 phenotypes, five had expanded (> 10%) sCD3CD4CD7 T-cells, and two displayed aberrant CD8 T-LGL populations. Clonality was established in all patients with nonclassic phenotypes by molecular TCR testing or based on uniform TRBC1. We assessed a serial gating strategy to quantify the classic L-HES phenotype and found this to be highly sensitive and specific with an estimated limit of detection of 0.06% of lymphocytes. Using this strategy, we identified decreased but detectable abnormal T-cells in all classic phenotype patients reassessed posttreatment, down to as low as 0.3% of lymphocytes. The identification of T-LGL phenotypes with eosinophilia is a novel finding.
Our study highlights the diverse immunophenotypic spectrum of L-HES, emphasizing the importance of comprehensive flow cytometry analysis for accurate diagnosis.
淋巴细胞变异型嗜酸性粒细胞增多综合征(L-HES)是一种罕见疾病,其特征为异常T细胞群体驱动的持续性嗜酸性粒细胞增多。由于缺乏标准化诊断标准,诊断仍然具有挑战性。
我们回顾性分析了2016年至2023年间诊断为L-HES的18例患者。对外周血样本进行了全面的流式细胞术检测。
9例患者表现出经典的sCD3CD4CD5CD2CD45ROCD45RA免疫表型,占淋巴细胞总数的0.6%至70%。2例患者表现出变异的sCD3CD4表型,5例患者sCD3CD4CD7 T细胞扩增(>10%),2例患者表现出异常的CD8 T-LGL群体。通过分子TCR检测或基于统一的TRBC1,在所有非经典表型患者中确定了克隆性。我们评估了一种连续门控策略来量化经典的L-HES表型,发现其具有高度敏感性和特异性,估计检测限为淋巴细胞的0.06%。使用该策略,我们在所有接受治疗后重新评估的经典表型患者中发现异常T细胞数量减少但仍可检测到,低至淋巴细胞的0.3%。嗜酸性粒细胞增多的T-LGL表型的鉴定是一项新发现。
我们的研究突出了L-HES多样的免疫表型谱,强调了全面流式细胞术分析对准确诊断的重要性。